Pay in 4 interest-free payments of $6.16 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
k , Immunoblot of SLC25A39 and ATF4 proteins in HeLa cells treated with indicated doses of mitoCDNB, diamide and BSO (1 mM)/erastin (5 M) for 24 h
Expansion of combination therapies The expansion of combination therapies is helping drive growth quite a lot in the global GLP-1 agonists market, its like people are using these medicines in a more layered way
Prioritise protein to protect muscle Research suggests that people losing weight on GLP-1 receptor agonists often fall well short of recommended protein targets, which can accelerate muscle loss
Jerz G, Elnakady YA, Braun A, Jckel K, Sasse F, Al Ghamdi AA, Omar MO, Winterhalter P
US$ 26.29
US$ 27.68
US$ 20.00
US$ 25.47
US$ 25.66
US$ 27.01
US$ 27.83
US$ 21.30
US$ 20.97
US$ 21.91
US$ 20.06
US$ 20.30
US$ 29.01
US$ 20.76
